US 6682728
Efficient and selective adenoviral-mediated gene transfer into vascular neointima
expired A61KA61K38/45A61K48/00
Quick answer
US patent 6682728 (Efficient and selective adenoviral-mediated gene transfer into vascular neointima) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jan 27 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/45, A61K48/00